These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3630713)

  • 1. Post-antibiotic effect and killing activity of ciprofloxacin against Staphylococcus aureus.
    Fuursted K
    Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):199-202. PubMed ID: 3630713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
    Odenholt I; Löwdin E; Cars O
    Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of post-antibiotic lag and repair-recovery to the post-antibiotic effects of ciprofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1993; 39(1):22-31. PubMed ID: 8444058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
    Røder BL; Gutschik E
    J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-antibiotic effects of RP 59500 with Staphylococcus aureus.
    Nougayrede A; Berthaud N; Bouanchaud DH
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():101-6. PubMed ID: 1399941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.
    Smith SM; Eng RH; Berman E
    J Antimicrob Chemother; 1986 Mar; 17(3):287-95. PubMed ID: 2939049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study on growth kinetics of organisms causing purulent infections in the presence of ofloxacin and ciprofloxacin].
    Skala LZ
    Antibiot Khimioter; 1991 Nov; 36(11):21-4. PubMed ID: 1793289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
    Dosler S; Gerceker AA
    Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
    Richards RM; Hamilton VE; Thomas MR
    J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
    Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
    Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
    Gupta S; Agarwal S; Sahoo DR; Muralidharan S
    Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus.
    Páez PL; Becerra MC; Albesa I
    FEMS Microbiol Lett; 2010 Feb; 303(1):101-5. PubMed ID: 20030722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents.
    Aldridge KE; Gelfand MS; Schiro DD; Barg NL
    Diagn Microbiol Infect Dis; 1992; 15(7):601-8. PubMed ID: 1424517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.